Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians

NCT ID: NCT06626672

Last Updated: 2025-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Congenital heart disease (CHD) affects approximately 1% of live births, and children with CHD often fail to meet WHO physical activity guidelines. Digital interventions to promote physical activity in CHD patients are limited. This study will develop and test a 12-week digital lifestyle intervention for children (ages 8-13) and their guardians, using a Garmin Vivofit Jr. 2 wearable to continuously monitor physical activity (PA). We will assess its impact on children's moderate to vigorous intensity physical activity (MVPA), daily activity (steps per day), quality of life, nutrition, and health literacy, as well as the quality of life and health literacy of their parents.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease Pediatric ALL

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study uses a delayed start design with two arms. In Arm 1, participants receive the intervention immediately for 12 weeks. In Arm 2, participants initially do not receive the intervention but will start the same intervention after a 12-week delay to ensure fairness.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Digital Health Intervention

Children and their guardians are given access to a 12-week digital platform with content to improve their lifestyle.

Physical activity is monitored with a Garmin Vivofit Jr. 2.

Group Type EXPERIMENTAL

Digital Health Intervention

Intervention Type BEHAVIORAL

Access to a digital platform including weekly workout videos, live workouts, recipes, study summaries, and a consultation hour.

Control

During 12-week control period participants receive no access the digital platform. Physical activity is monitored with a Garmin Vivofit Jr. 2.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital Health Intervention

Access to a digital platform including weekly workout videos, live workouts, recipes, study summaries, and a consultation hour.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 8-14 years
* Presence of a congenital heart defect (must be moderate or complex according to ACC criteria)
* NYHA Class I or II
* Presence of written informed consent

Exclusion Criteria

* Cognitive impairments that inhibit patients from understanding the tasks
* No sports clearance by paediatric cardiologists
Minimum Eligible Age

8 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technical University of Munich

OTHER

Sponsor Role collaborator

Stiftung KinderHerz Deutschland gGmbH

UNKNOWN

Sponsor Role collaborator

Deutsches Herzzentrum Muenchen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jan Müller, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich, Chair of preventive perdiatrics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Paediatric Cardiology and Congenital Heart Defects, German Heart Center of the State Bavaria (Munich), Technical University of Munich (TUM)

München, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jan Müller, Prof. Dr.

Role: CONTACT

‭0176 21149304‬

Isabel Uphoff, M.Sc.

Role: CONTACT

01639104022

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jan Müller, PhD

Role: primary

+4989289 ext. 24574

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-337-S-SB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lifestyle Intervention for Heart Failure
NCT00633633 ACTIVE_NOT_RECRUITING NA
Wearables and Cardiac Rehabilitation
NCT06065319 ACTIVE_NOT_RECRUITING
Fontan Fitness Trial
NCT06918795 RECRUITING NA
Heart Cycle Prestudy
NCT01627457 COMPLETED NA